Statine-derived tetrapeptide inhibitors of beta-secretase
CA 2376420 A1 · Owner: John, Varghese · Inventors: John, Varghese; Mamo, Shumeye S.; Fang, Lawrence
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Statine-derived peptide inhibitors of the .beta.-secretase enzyme are provided which are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A.beta. peptide in a mammal. The compounds of the invention provide useful methods of treatment by administration of these inhibitors to reduce A.beta. peptide formation and pharmaceutical compositions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 15, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 15, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 15, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.